+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Asia Pacific Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type; Application; End User, and, Country

  • PDF Icon

    Report

  • 117 Pages
  • August 2020
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5147225
UP TO OFF until Jun 30th 2024
The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027.

The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system. However, the market is likely to have negative impact due to lack of adoption in emerging countries.

In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of several chronic diseases. However, the majority of the available treatment options require parenteral drug administration, frequent dosing, and repeated hospital visits. Treatment administration via the parenteral route is associated with concerns such as dosing errors, microbial contamination risks, and needle stick injuries. These are found to be the primary factors affecting medication adherence and, thereby affecting significantly on therapeutic outcomes. Over the years, several companies have developed advanced therapeutic delivery solutions such as wearable autoinjectors and pen injectors to overcome the challenges associated with the administration of viscous and large molecule drugs. Moreover, the concept of self-injection reduces healthcare costs and allow the optimal usage of healthcare resources.

Wearable injectors present a robust solution for increasing dosing volumes and viscosities in non-clinical settings. Specifically, large volume wearable injectors are being used for subcutaneous drug delivery and have become a preferred choice for the administration of drugs in the home-care setting. Variants of these wearable devices have been designed to administer highly viscous drugs (such as biologics) in large volumes (more than 1 mL), offering numerous dosing options, integrated safety mechanisms, and minimum risk of needle stick injuries. Besides this, it is crucial to ensure safety of healthcare providers.

Moreover, managing needle stick injuries incurs high costs to any healthcare facility. The number of problems associated with conventional drug delivery methods and advantages offered by wearable injectors such as accurate dosage, fewer visits to hospitals, and compatibility with high volume drugs are among the factors likely to increase their adoption rate during the forecast period.

Thus, conventional drug delivery system limitations contributing to the growth of the Asia Pacific Wearable Injectors market in the forecast period.

Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. The on-body injectors segment held the largest share of the market in 2019. However, the off-body injectors segment is estimated to register the highest CAGR of 13.0% in the market during the forecast period.

Based on application, the market is segmented into oncology, diabetes, autoimmune diseases, cardiovascular disease and other applications. The oncology segment held the largest share of the market in 2019. However, the autoimmune disease segment is estimated to register the highest CAGR of 13.4% in the market during the forecast period.

Based on end user, the market is segmented into homecare settings, hospital and clinical and other end users. The homecare setting segment held the largest share of the market in 2019. However, the hospitals and clinics segment is estimated to register the highest CAGR of 13.0% in the market during the forecast period
Some of the major primary and secondary sources for Asia Pacific Wearable Injectors market included in the report are, The National Center for Biotechnology Information, World Health Organization, Health Ministry of Japan, International Diabetes Federation, The Indian Council for Medical Research and others.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Wearable Injectors Market - By Type
1.3.2 Asia Pacific Wearable Injectors Market - By Application
1.3.3 Asia Pacific Wearable Injectors Market - By End User
1.3.4 Asia Pacific Wearable Injectors Market - By Country
2. Asia Pacific Wearable Injectors Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Wearable Injectors Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 4.2.1 Asia Pacific Wearable Injectors Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Wearable Injectors Market - Key Market Dynamics
5. Wearable Injectors Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Chronic Diseases Prevalence
5.1.2 Technological Advancements and Design Development
5.1.3 Conventional Drug Delivery System Limitations
5.2 Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Increasing Demand for Biologics
5.4 Future Trends
5.4.1 Integration of Wearable Injectors During Early Drug Development
5.5 Impact Analysis
6. Wearable Injectors Market - Asia Pacific Analysis
6.1 Asia Pacific Wearable Injectors Market Revenue Forecast and Analysis
6.2 Asia Pacific Wearable Injectors Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Wearable Injectors Market- By Type
7.1 Overview
7.2 Wearable Injectors Market Share, by Type, 2019 and 2027 (%)
7.4 On-body Injectors
7.4.1 Overview
7.4.2 On-body Injectors: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
7.5 Off-body Injectors
7.5.1 Overview
7.5.2 Off-body Injectors: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
8. Wearable Injectors Market- By Application
8.1 Overview
8.2 Wearable Injectors Market Share, by Application, 2019 and 2027 (%)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.5 Diabetes
8.5.1 Overview
8.5.2 Diabetes: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.6 Autoimmune Disease
8.6.1 Overview
8.6.2 Autoimmune Disease: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.7 Cardiovascular Disease
8.7.1 Overview
8.7.2 Cardiovascular Disease: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
9. Wearable Injectors Market- By End User
9.1 Overview
9.2 Wearable Injectors Market Share, by End user, 2019 and 2027 (%)
9.4 Homecare Setting
9.4.1 Overview
9.4.2 Homecare Setting: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
9.5 Hospitals and Clinics
9.5.1 Overview
9.5.2 Hospitals and Clinics: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
9.6 Other End Users
9.6.1 Overview
9.6.2 Other End Users: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10. Wearable Injectors Market - Geographic Analysis
10.3 Asia Pacific: Wearable Injectors Market
10.3.1 Overview
10.3.2 Asia Pacific: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia Pacific Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.5 Asia Pacific Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)
10.3.7 China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.7.4 China Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.8.4 Japan Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.9.4 India Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.10.4 South Korea Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Wearable Injectors Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Wearable Injectors Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Wearable Injectors Market, by Application- Revenue and Forecast to 2027(USD Million)
10.3.11.4 Australia Wearable Injectors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Wearable Injectors Market
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12. Wearable Injectors Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 BD
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 CeQur SA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Debiotech S.A.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 E3D Elcam Drug Delivery Devices
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Gerresheimer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Tandem Diabetes Care Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 West Pharmaceutical Services, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Ypsomed AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medtronic
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Amgen, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. China Wearable Injectors Market, by Type – Revenue and Forecast to 2027(USD Million)
Table 5. China Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. China Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Wearable Injectors Market, by Type – Revenue and Forecast to 2027(USD Million)
Table 8. Japan Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Japan Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. India Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. India Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. India Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. South Korea Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. South Korea Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. South Korea Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Australia Wearable Injectors Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Australia Wearable Injectors Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Australia Wearable Injectors Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. List of Abbreviation
List of Figures
Figure 1. Asia Pacific Wearable Injectors Market Segmentation
Figure 2. Asia Pacific Wearable Injectors Market Overview
Figure 3. Off-body injectors Segment Held Largest Share of Product Segment in Wearable Injectors Market
Figure 4. China Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Wearable Injectors Market- Leading Country Markets (US$ Mn)
Figure 6. Asia Pacific Wearable Injectors Market - Asia Pacific PEST Analysis
Figure 7. Asia Pacific Wearable Injectors Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Wearable Injectors Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Wearable Injectors Market Revenue Share, by Type (2019 and 2027)
Figure 10. Oral Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Off-body injectors: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Topical Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Ocular Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Pulmonary Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Nasal Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Transmucosal Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Implantable Drug Delivery: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Asia Pacific Wearable Injectors Market Revenue Share, by Application (2019 and 2027)
Figure 19. Infectious Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cardiovascular Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Diabetes: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Respiratory Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Central Nervous Systems Disorders: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Autoimmune Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Other Diseases: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Asia Pacific Wearable Injectors Market Share, by End User, 2019 and 2027 (%)
Figure 28. Hospitals: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Home Care Settings: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. ASCs/ Clinics: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Other End Users: Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Asia Pacific: Wearable Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. Asia Pacific Wearable Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 34. Asia Pacific: Wearable Injectors Market, by Country, 2019 & 2027 (%)
Figure 35. China: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Japan: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. India: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. South Korea: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Australia: Wearable Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BD
  • CeQur SA
  • Debiotech S.A
  • E3D Elcam Drug Delivery Devices
  • Gerresheimer AG
  • Tandem Diabetes Care Inc
  • West Pharmaceutical Services, Inc
  • Ypsomed AG
  • Medtronic
  • Amgen, Inc.